5 Best Weight Loss Drug Stocks to Buy Now

4. DexCom, Inc. (NASDAQ:DXCM)

Number of Q4 2023 Hedge Fund Shareholders: 69

DexCom, Inc. (NASDAQ:DXCM) is a medical device manufacturer headquartered in San Diego, California. While it doesn’t make weight loss drugs, data from the firm released in September 2023 outlined that its product sales grew as more people used weight loss drugs to measure their insulin in real time.

During December 2023, 69 out of the 933 hedge funds part of Insider Monkey’s database were the firm’s shareholders. DexCom, Inc. (NASDAQ:DXCM)’s largest hedge fund investor is Ken Griffin’s Citadel Investment Group through its $294 million investment.

Follow Dexcom Inc (NASDAQ:DXCM)